With the new acquisition, Vivo will now have 55 ambulatory infusion sites across 10 states, according to a June 20 press release.
Specialty Infusion offers therapies across allergy/immunology, gastroenterology, neurology, and rheumatology.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
